Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 6—June 2026
Research
Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022–2024
, Sebastiaan J. Van Hal1, Cecilia Li, Steven J. Nigro, Ellen Donnan, Nathan Ryder, Monica Lahra2, and Janaki Amin2
Table 1
Tests and notifications of Neisseria gonorrhoeae, New South Wales, Australia, 2022–2024*
| Characteristic | No. (%) |
|||
|---|---|---|---|---|
| 2022 | 2023 | 2024 | Total | |
| All positive and negative test results† |
775,161 (100) |
868,741 (112.1)‡ |
876,447 (113.1)‡ |
2,520,349 (NA) |
| All N. gonorrhoeae notifications§ | 10,288 (100.0) | 12,453 (100.0) | 14,045 (100.0) | 36,786 (100.0) |
| F | 2,066 (20.1) | 2,651 (21.3) | 2,789 (19.9) | 7,506 (20.4) |
| M |
8,194 (79.6) |
9,759 (78.4) |
11,216 (79.9) |
29,169 (79.3) |
| N. gonorrhoeae notifications with positive culture§¶ | 2,734 (26.6) | 3,558 (28.6) | 3,649 (26.0) | 9,941 (27.0) |
| F | 455 (22.0) | 631 (23.8) | 609 (21.8) | 1,695 (22.6) |
| M |
2,267 (27.7) |
2,914 (29.9) |
3,028 (27.0) |
8,209 (28.1) |
| N. gonorrhoeae AMR notifications of PHC# | 29 (1.1) | 17 (0.5) | 48 (1.3) | 94 (0.9) |
| F | 6 (1.3) | 3 (0.5) | 9 (1.5) | 18 (1.1) |
| M | 23 (1.0) | 14 (0.5) | 39 (1.3) | 76 (0.9) |
*AMR, antimicrobial resistance; NA, not applicable; PHC, public health concern. †Aggregate gonorrhea test results by nucleic acid amplification test and culture from 12 laboratories. Those laboratories account for an estimated 88.0% of all gonorrhea testing in New South Wales. ‡Percentage calculated from baseline tests in 2022. §Includes persons whose sex was not reported. ¶Percentage calculated from all N. gonorrhoeae notifications. #Percentage calculated from N. gonorrhoeae culture notifications.
1These first authors contributed equally to this article.
2These joint senior authors contributed equally to this article.